Peripheral neuropathy, damage to the peripheral nerves that results in pain, numbness, tingling, and weakness, typically in the hands and feet, affects an estimated 20 million Americans. Conventional management relies heavily on medications that often provide incomplete relief and carry significant side effects. Cold laser therapy has emerged as a promising non-pharmaceutical option with a growing body of clinical evidence.
Understanding Peripheral Neuropathy
The peripheral nervous system includes all nerves outside the brain and spinal cord. Damage to these nerves disrupts the signals they carry, producing the characteristic symptoms of neuropathy. Common causes include diabetes (the most prevalent), chemotherapy, vitamin deficiencies, autoimmune conditions, alcoholism, and nerve compression. Once nerve damage occurs, recovery is typically slow, making early intervention critical.
How Cold Laser Therapy Works for Neuropathy
Cold laser therapy, specifically at wavelengths in the near-infrared range (810-980 nm), has demonstrated the ability to stimulate nerve regeneration and repair through several mechanisms. It increases mitochondrial activity in damaged nerve cells, promoting the production of ATP energy needed for repair. It reduces neuroinflammation and oxidative stress in nerve tissue. Research has also shown it can promote axonal sprouting, the regrowth of nerve fibers, in damaged peripheral nerves.
Clinical Evidence
Multiple studies have documented significant reductions in neuropathic pain, improvements in sensation, and enhanced nerve conduction velocity following cold laser treatment. For chemotherapy-induced peripheral neuropathy, studies show that laser therapy can reduce symptoms and support quality of life without interfering with cancer treatment.
Treatment at Shin Wellness
Our cold laser protocol for peripheral neuropathy is individualized based on the location and severity of nerve involvement. Treatment is comfortable and non-invasive, requiring no recovery time. Most patients receive 2-3 sessions per week over 6-8 weeks, with outcomes assessed throughout the course of care.